Validation of the Barcelona-MRI predictive model when PI-RADS v2.1 is used with transperineal prostate biopsies
ABSTRACT Purpose: To validate the Barcelona magnetic resonance imaging predictive model (BCN-MRI PM) in men with pre-biopsy multiparametric MRI (mpMRI) reported with the Prostate Imaging Reporting and Data System (PI-RADS) v2.1, followed by transrectal and transperineal prostate biopsies. Materials...
Saved in:
| Published in | International Brazilian Journal of Urology Vol. 50; no. 5; pp. 595 - 604 |
|---|---|
| Main Authors | , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Sociedade Brasileira de Urologia
01.09.2024
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 1677-5538 1677-6119 |
| DOI | 10.1590/s1677-5538.ibju.2024.0204 |
Cover
| Abstract | ABSTRACT Purpose: To validate the Barcelona magnetic resonance imaging predictive model (BCN-MRI PM) in men with pre-biopsy multiparametric MRI (mpMRI) reported with the Prostate Imaging Reporting and Data System (PI-RADS) v2.1, followed by transrectal and transperineal prostate biopsies. Materials and Methods: Prospective analysis of 3,264 men with PSA >3.0 ng/mL and/or abnormal digital rectal examination who were referred to ten participant centers in the csPCa early detection program of Catalonia (Spain), between 2021 and 2023. MpMRI was reported with the PI-RADS v2.1, and 2- to 4-core MRI-transrectal ultrasound (TRUS) fusion-targeted biopsy of suspected lesions and/or 12-core systematic biopsy were conducted. 2,295 (70.3%) individuals were referred to six centers for transrectal prostate biopsies, while 969 (39.7%) were referred to four centers for transperineal prostate biopsies. CsPCa was classified whenever the International Society of Urologic Pathology grade group was 2 or higher. Results: CsPCa was detected in 41% of transrectal prostate biopsies and in 45.9% of transperineal prostate biopsies (p <0.016). Both BCN-MRI PM calibration curves were within the ideal correlation between predicted and observed csPCa. Areas under the curve and 95% confidence intervals were 0.847 (0.830-0.857) and 0.830 (0.823-0.855), respectively (p = 0.346). Specificities corresponding to 95% sensitivity were 37.6 and 36.8%, respectively (p = 0.387). The Net benefit of the BCN-MRI PM was similar with both biopsy methods. Conclusions: The BCN-MRI PM has been successfully validated when mpMRI was reported with the PI-RADS v2.1 and prostate biopsies were conducted via the transrectal and transperineal route. |
|---|---|
| AbstractList | ABSTRACT Purpose: To validate the Barcelona magnetic resonance imaging predictive model (BCN-MRI PM) in men with pre-biopsy multiparametric MRI (mpMRI) reported with the Prostate Imaging Reporting and Data System (PI-RADS) v2.1, followed by transrectal and transperineal prostate biopsies. Materials and Methods: Prospective analysis of 3,264 men with PSA >3.0 ng/mL and/or abnormal digital rectal examination who were referred to ten participant centers in the csPCa early detection program of Catalonia (Spain), between 2021 and 2023. MpMRI was reported with the PI-RADS v2.1, and 2- to 4-core MRI-transrectal ultrasound (TRUS) fusion-targeted biopsy of suspected lesions and/or 12-core systematic biopsy were conducted. 2,295 (70.3%) individuals were referred to six centers for transrectal prostate biopsies, while 969 (39.7%) were referred to four centers for transperineal prostate biopsies. CsPCa was classified whenever the International Society of Urologic Pathology grade group was 2 or higher. Results: CsPCa was detected in 41% of transrectal prostate biopsies and in 45.9% of transperineal prostate biopsies (p <0.016). Both BCN-MRI PM calibration curves were within the ideal correlation between predicted and observed csPCa. Areas under the curve and 95% confidence intervals were 0.847 (0.830-0.857) and 0.830 (0.823-0.855), respectively (p = 0.346). Specificities corresponding to 95% sensitivity were 37.6 and 36.8%, respectively (p = 0.387). The Net benefit of the BCN-MRI PM was similar with both biopsy methods. Conclusions: The BCN-MRI PM has been successfully validated when mpMRI was reported with the PI-RADS v2.1 and prostate biopsies were conducted via the transrectal and transperineal route. |
| Author | Celma, Ana Servian, Pol Muñoz-Rodriguez, Jesús Ruiz-Plazas, Xavier Miró, Berta Abascal, José M. Paesano, Nahuel Morote, Juan Picola, Natàlia Muñoz-Rivero, Marta V. Manuel, Gemma García-de |
| Author_xml | – sequence: 1 givenname: Juan orcidid: 0000-0002-2168-323X surname: Morote fullname: Morote, Juan organization: Hospital Univeritari Vall d'Hebron, Spain; Universitat Autònoma de Barcelona, Spain – sequence: 2 givenname: Nahuel surname: Paesano fullname: Paesano, Nahuel organization: Universitat Autònoma de Barcelona, Spain; Clínica Creu Blanca, Spain – sequence: 3 givenname: Natàlia surname: Picola fullname: Picola, Natàlia organization: Hospital Universitari de Bellvitge, Spain – sequence: 4 givenname: Jesús surname: Muñoz-Rodriguez fullname: Muñoz-Rodriguez, Jesús organization: Hospital Universitari Parc Tauli, Spain – sequence: 5 givenname: Xavier surname: Ruiz-Plazas fullname: Ruiz-Plazas, Xavier organization: Hospital Universitari Joan XXIII, Spain – sequence: 6 givenname: Marta V. surname: Muñoz-Rivero fullname: Muñoz-Rivero, Marta V. organization: Hospital Universitari Arnau de Vilanova, Spain – sequence: 7 givenname: Ana surname: Celma fullname: Celma, Ana organization: Hospital Univeritari Vall d'Hebron, Spain – sequence: 8 givenname: Gemma García-de surname: Manuel fullname: Manuel, Gemma García-de organization: Hospital Universitari Josep Trueta, Spain – sequence: 9 givenname: Berta surname: Miró fullname: Miró, Berta organization: Vall d'Hebron Research Institute, Spain – sequence: 10 givenname: Pol surname: Servian fullname: Servian, Pol organization: Hospital Univeritari Germans Trias i Pujol, Spain – sequence: 11 givenname: José M. surname: Abascal fullname: Abascal, José M. organization: Parc de Salut Mar, Spain; Universitat Pompeu Fabra, Spain |
| BookMark | eNqFkdtu1DAQhi3Uih7gHcwDJPic-AqVUmClolYtcGvZzrjrVTaOYu9WvD3JtiCVG65sef75Rp7vDB0NaQCE3lFSU6nJ-0xV01RS8raObrOrGWGiJoyIV-j0UFKU6qPn-xI7QWc5bwhhmjT0NTrhmpI5I09R-mn72NkS04BTwGUN-KOdPPRpsNW3uxUeJ-iiL3EPeJs66PHjGgZ8u6ruLj7d4z2rKY4Z7zJ0-DGWNS6THfIIUxzA9nN3ysUWwC6mMUfIb9BxsH2Gt8_nOfrx-er75dfq-ubL6vLiuvKi4aWy4JrWOiIZMBnA6UYorkNDOkFEozoSpOI--NCqQCQJTDhQnLdKSM1b5vk5Wj1xu2Q3Zpzi1k6_TLLRHB7S9GDsVKLvwXgN2jOlKHgunFLOAZdOi5Yr6zvlZtaHJ9a4c1voPAzzJ_sX0JeVIa7NQ9obSoVQchbwl-DnfeQJgvGxHJY-52NvKDGLWHMQaxZjZhFrFrFmETsT9D-EP-P_3_sb7Pusig |
| CitedBy_id | crossref_primary_10_3390_cancers17030473 crossref_primary_10_1590_s1677_5538_ibju_2024_0630 |
| Cites_doi | 10.1038/s41391-023-00729-4 10.1016/j.ejso.2021.04.033 10.1056/NEJMoa0810084 10.1590/s1677-5538.ibju.2024.0084 10.1007/s00345-020-03177-0 10.1016/j.urolonc.2023.09.020 10.1001/jamanetworkopen.2024.1516 10.1002/bco2.230 10.1016/j.eururo.2021.07.024 10.1038/s41585-022-00638-6 10.1016/j.euros.2021.11.008 10.1016/j.urolonc.2020.11.010 10.1007/s00345-021-03770-x 10.1016/j.eururo.2019.02.033 10.3390/cancers14194747 10.1007/s00330-011-2377-y 10.3390/jpm14020130 10.3390/cancers14205100 10.1016/j.euros.2022.06.002 10.1590/s1677-5538.ibju.2023.0558 10.1590/s1677-5538.ibju.2023.0321 10.1016/j.euros.2021.08.004 10.1097/PAS.0000000000000530 10.1016/j.eururo.2023.08.002 10.1016/j.eururo.2020.12.010 10.3390/cancers14061589 10.5534/wjmh.230028 10.1136/bmj.h5527 10.1016/j.jbi.2015.05.001 10.1016/j.urolonc.2023.05.003 10.1016/j.euros.2023.03.013 10.1016/j.ymeth.2022.03.005 10.1097/JU.0000000000002696 10.1016/j.urolonc.2023.05.011 10.5152/tud.2020.20111 10.1590/s1677-5538.ibju.2023.0060 |
| ContentType | Journal Article |
| DBID | AAYXX CITATION 5PM DOA |
| DOI | 10.1590/s1677-5538.ibju.2024.0204 |
| DatabaseName | CrossRef PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef |
| DatabaseTitleList | |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1677-6119 |
| EndPage | 604 |
| ExternalDocumentID | oai_doaj_org_article_c9e9c2661ec34b66bbe35b94836acd6b PMC11446555 10_1590_s1677_5538_ibju_2024_0204 |
| GrantInformation_xml | – fundername: Instituto de Salut Carlos III (SP) and the European Union grantid: PI20/01666 |
| GroupedDBID | --- 29J 2WC 53G 5GY 5VS AAYXX ABXHO ADBBV ADRAZ AENEX ALMA_UNASSIGNED_HOLDINGS AOIJS APOWU AZFZN BAWUL BCNDV C1A CITATION CS3 DIK E3Z EBS EJD F5P FRP GROUPED_DOAJ HYE IPNFZ KQ8 M48 OK1 OVT PGMZT RIG RNS RPM RSC SCD TR2 W2D XSB 5PM |
| ID | FETCH-LOGICAL-c473t-aeb78ab052e25feb974639f70d40476d0f563cfcf86f050f24be63386459382c3 |
| IEDL.DBID | DOA |
| ISSN | 1677-5538 |
| IngestDate | Wed Aug 27 01:31:04 EDT 2025 Thu Aug 21 18:34:54 EDT 2025 Tue Jul 01 02:08:19 EDT 2025 Thu Apr 24 23:08:58 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 5 |
| Language | English |
| License | http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c473t-aeb78ab052e25feb974639f70d40476d0f563cfcf86f050f24be63386459382c3 |
| Notes | CONFLICT OF INTEREST: None declared. |
| ORCID | 0000-0002-2168-323X |
| OpenAccessLink | https://doaj.org/article/c9e9c2661ec34b66bbe35b94836acd6b |
| PMID | 39106115 |
| PageCount | 10 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_c9e9c2661ec34b66bbe35b94836acd6b pubmedcentral_primary_oai_pubmedcentral_nih_gov_11446555 crossref_citationtrail_10_1590_s1677_5538_ibju_2024_0204 crossref_primary_10_1590_s1677_5538_ibju_2024_0204 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2024-09-01 |
| PublicationDateYYYYMMDD | 2024-09-01 |
| PublicationDate_xml | – month: 09 year: 2024 text: 2024-09-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationTitle | International Brazilian Journal of Urology |
| PublicationYear | 2024 |
| Publisher | Sociedade Brasileira de Urologia |
| Publisher_xml | – name: Sociedade Brasileira de Urologia |
| References | Remmers S (ref35) 2021; 36 van den Bergh RCN (ref12) 2021; 32 Van Poppel H (ref2) 2021; 80 Van Poppel H (ref28) 2023; 84 Morote J (ref8) 2022; 14 Van Poppel H (ref6) 2022; 19 Rico L (ref16) 2021; 39 Paesano N (ref19) 2024; 50 Morote J (ref31) 2023; 41 Morote J (ref32) 2023; 4 Epstein JI (ref14) 2016; 40 Bossuyt PM (ref15) 2015; 351 Patel HD (ref25) 2024; 7 TVan Poppel H (ref1) 2021; 79 Triquell M (ref7) 2022; 14 Barentsz JO (ref13) 2012; 22 Morote J (ref34) 2024; 14 Turkbey B (ref11) 2019; 76 Morote J (ref33) 2024; 42 Frånlund M (ref4) 2022; 208 Schmit S (ref36) 2024; 50 Lv Z (ref18) 2023; 49 Strobl AN (ref37) 2015; 56 Schröder FH (ref3) 2009; 360 Morote J (ref29) 2022; 14 Kaneko M (ref26) 2024; 50 Van Poppel H (ref5) 2021; 80 Morote J (ref10) 2022; 42 Wu Q (ref20) 2024; 27 Morote J (ref30) 2024; 42 Chen R (ref22) 2021; 39 O’ Callaghan ME (ref21) 2023; 41 Nandi A (ref38) 2022; 204 Rico L (ref17) 2020; 46 Petersmann AL (ref24) 2021; 39 Morote J (ref9) 2023; 53 De Nunzio C (ref23) 2021; 47 Remmers S (ref27) 2021; 36 |
| References_xml | – volume: 27 start-page: 212 year: 2024 ident: ref20 article-title: Transperineal magnetic resonance imaging targeted biopsy versus transrectal route in the detection of prostate cancer: a systematic review and meta-analysis publication-title: Prostate Cancer Prostatic Dis doi: 10.1038/s41391-023-00729-4 – volume: 47 start-page: 2640 year: 2021 ident: ref23 article-title: Rotterdam mobile phone app including MRI data for the prediction of prostate cancer: A multicenter external validation publication-title: Eur J Surg Oncol doi: 10.1016/j.ejso.2021.04.033 – volume: 360 start-page: 1320 year: 2009 ident: ref3 article-title: Screening and prostate-cancer mortality in a randomized European study publication-title: N Engl J Med doi: 10.1056/NEJMoa0810084 – volume: 50 start-page: 319 year: 2024 ident: ref26 article-title: A nomogram to predict the absence of clinically significant prostate cancer in males with negative MRI publication-title: Int Braz J Urol doi: 10.1590/s1677-5538.ibju.2024.0084 – volume: 39 start-page: 73 year: 2021 ident: ref22 article-title: Comparing the prediction of prostate biopsy outcome using the Chinese Prostate Cancer Consortium (CPCC) Risk Calculator and the Asian adapted Rotterdam European Randomized Study of Screening for Prostate Cancer (ERSPC) Risk Calculator in Chinese and European men publication-title: World J Urol doi: 10.1007/s00345-020-03177-0 – volume: 36 start-page: 1 year: 2021 ident: ref35 article-title: Reducing Biopsies and Magnetic Resonance Imaging Scans During the Diagnostic Pathway of Prostate Cancer: Applying the Rotterdam Prostate Cancer Risk Calculator to the PRECISION Trial Data publication-title: Eur Urol Open Sci – volume: 42 start-page: 115.e1 year: 2024 ident: ref33 article-title: Reducing the demand for magnetic resonance imaging scans and prostate biopsies during the early detection of clinically significant prostate cancer: Applying the Barcelona risk-stratified pathway in Catalonia publication-title: Urol Oncol doi: 10.1016/j.urolonc.2023.09.020 – volume: 7 year: 2024 ident: ref25 article-title: Comparison of Magnetic Resonance Imaging-Based Risk Calculators to Predict Prostate Cancer Risk publication-title: JAMA Netw Open doi: 10.1001/jamanetworkopen.2024.1516 – volume: 4 start-page: 420 year: 2023 ident: ref32 article-title: A risk-organised model for clinically significant prostate cancer early detection publication-title: BJUI Compass doi: 10.1002/bco2.230 – volume: 80 start-page: 703 year: 2021 ident: ref5 article-title: Prostate-specific Antigen Testing as Part of a Risk-Adapted Early Detection Strategy for Prostate Cancer: European Association of Urology Position and Recommendations for 2021 publication-title: Eur Urol doi: 10.1016/j.eururo.2021.07.024 – volume: 80 start-page: 703 year: 2021 ident: ref2 article-title: Prostate-specific Antigen Testing as Part of a Risk-Adapted Early Detection Strategy for Prostate Cancer: European Association of Urology Position and Recommendations for 2021 publication-title: Eur Urol doi: 10.1016/j.eururo.2021.07.024 – volume: 19 start-page: 562 year: 2022 ident: ref6 article-title: Serum PSA-based early detection of prostate cancer in Europe and globally: past, present and future publication-title: Nat Rev Urol doi: 10.1038/s41585-022-00638-6 – volume: 36 start-page: 19 year: 2021 ident: ref27 article-title: Updating the Rotterdam Prostate Cancer Risk Calculator with Invasive Cribriform and/or Intraductal Carcinoma for Men with a Prior Negative Biopsy publication-title: Eur Urol Open Sci doi: 10.1016/j.euros.2021.11.008 – volume: 39 start-page: 431.e9 year: 2021 ident: ref16 article-title: PI-RADS 3 lesions: Does the association of the lesion volume with the prostate-specific antigen density matter in the diagnosis of clinically significant prostate cancer? publication-title: Urol Oncol doi: 10.1016/j.urolonc.2020.11.010 – volume: 39 start-page: 4109 year: 2021 ident: ref24 article-title: External validation of two MRI-based risk calculators in prostate cancer diagnosis publication-title: World J Urol doi: 10.1007/s00345-021-03770-x – volume: 76 start-page: 340 year: 2019 ident: ref11 article-title: Prostate Imaging Reporting and Data System Version 2.1: 2019 Update of Prostate Imaging Reporting and Data System Version 2 publication-title: Eur Urol doi: 10.1016/j.eururo.2019.02.033 – volume: 14 start-page: 4747 year: 2022 ident: ref7 article-title: Magnetic Resonance Imaging-Based Predictive Models for Clinically Significant Prostate Cancer: A Systematic Review publication-title: Cancers (Basel) doi: 10.3390/cancers14194747 – volume: 22 start-page: 746 year: 2012 ident: ref13 article-title: ESUR prostate MR guidelines 2012 publication-title: Eur Radiol doi: 10.1007/s00330-011-2377-y – volume: 14 start-page: 130 year: 2024 ident: ref34 article-title: Investigating Efficient Risk-Stratified Pathways for the Early Detection of Clinically Significant Prostate Cancer publication-title: J Pers Med doi: 10.3390/jpm14020130 – volume: 14 start-page: 5100 year: 2022 ident: ref29 article-title: A Clinically Significant Prostate Cancer Predictive Model Using Digital Rectal Examination Prostate Volume Category to Stratify Initial Prostate Cancer Suspicion and Reduce Magnetic Resonance Imaging Demand publication-title: Cancers (Basel) doi: 10.3390/cancers14205100 – volume: 42 start-page: 40 year: 2022 ident: ref10 article-title: The True Utility of Predictive Models Based on Magnetic Resonance Imaging in Selecting Candidates for Prostate Biopsy publication-title: Eur Urol Open Sci doi: 10.1016/j.euros.2022.06.002 – volume: 50 start-page: 296 year: 2024 ident: ref19 article-title: The effectiveness of mapping-targeted biopsies on the index lesion in transperineal prostate biopsies publication-title: Int Braz J Urol doi: 10.1590/s1677-5538.ibju.2023.0558 – volume: 50 start-page: 37 year: 2024 ident: ref36 article-title: Less qualitative multiparametric magnetic resonance imaging in prostate cancer can underestimate extraprostatic extension in higher grade tumors publication-title: Int Braz J Urol doi: 10.1590/s1677-5538.ibju.2023.0321 – volume: 32 start-page: 43 year: 2021 ident: ref12 article-title: TREXIT Is Now: Should We Abandon the Transrectal Route for Biopsy? A Three-continent Debate-Referee publication-title: Eur Urol Open Sci doi: 10.1016/j.euros.2021.08.004 – volume: 40 start-page: 244 year: 2016 ident: ref14 article-title: The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System publication-title: Am J Surg Pathol doi: 10.1097/PAS.0000000000000530 – volume: 84 start-page: 519 year: 2023 ident: ref28 article-title: Early Detection of Prostate Cancer in the European Union: Combining Forces with PRAISE-U publication-title: Eur Urol doi: 10.1016/j.eururo.2023.08.002 – volume: 79 start-page: 327 year: 2021 ident: ref1 article-title: Early Detection of Prostate Cancer in 2020 and Beyond: Facts and Recommendations for the European Union and the European Commission publication-title: Eur Urol doi: 10.1016/j.eururo.2020.12.010 – volume: 14 start-page: 1589 year: 2022 ident: ref8 article-title: The Barcelona Predictive Model of Clinically Significant Prostate Cancer publication-title: Cancers (Basel) doi: 10.3390/cancers14061589 – volume: 42 start-page: 441 year: 2024 ident: ref30 article-title: The Role of Digital Rectal Examination Prostate Volume Category in the Early Detection of Prostate Cancer: Its Correlation with the Magnetic Resonance Imaging Prostate Volume publication-title: World J Mens Health doi: 10.5534/wjmh.230028 – volume: 351 start-page: h5527 year: 2015 ident: ref15 article-title: STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies publication-title: BMJ doi: 10.1136/bmj.h5527 – volume: 56 start-page: 87 year: 2015 ident: ref37 article-title: Improving patient prostate cancer risk assessment: Moving from static, globally-applied to dynamic, practice-specific risk calculators publication-title: J Biomed Inform doi: 10.1016/j.jbi.2015.05.001 – volume: 41 start-page: 299 year: 2023 ident: ref31 article-title: Are magnetic resonance imaging and targeted biopsies needed in men with serum prostate-specific antigen over 10 ng/mL and an abnormal digital rectal examination? publication-title: Urol Oncol doi: 10.1016/j.urolonc.2023.05.003 – volume: 53 start-page: 46 year: 2023 ident: ref9 article-title: Comparison of Rotterdam and Barcelona Magnetic Resonance Imaging Risk Calculators for Predicting Clinically Significant Prostate Cancer publication-title: Eur Urol Open Sci doi: 10.1016/j.euros.2023.03.013 – volume: 204 start-page: 340 year: 2022 ident: ref38 article-title: A federated learning method for real-time emotion state classification from multi-modal streaming publication-title: Methods doi: 10.1016/j.ymeth.2022.03.005 – volume: 208 start-page: 292 year: 2022 ident: ref4 article-title: Results from 22 years of Followup in the Göteborg Randomized Population-Based Prostate Cancer Screening Trial publication-title: J Urol doi: 10.1097/JU.0000000000002696 – volume: 41 start-page: 324.e13 year: 2023 ident: ref21 article-title: Trends and variation in prostate cancer diagnosis via transperineal biopsy in Australia and New Zealand publication-title: Urol Oncol doi: 10.1016/j.urolonc.2023.05.011 – volume: 46 start-page: 367 year: 2020 ident: ref17 article-title: Value of prostate-specific antigen density in negative or equivocal lesions on multiparametric magnetic resonance imaging publication-title: Turk J Urol doi: 10.5152/tud.2020.20111 – volume: 49 start-page: 359 year: 2023 ident: ref18 article-title: Is it necessary for all patients with suspicious lesions undergo systematic biopsy in the era of MRI-TRUS fusion targeted biopsy? publication-title: Int Braz J Urol doi: 10.1590/s1677-5538.ibju.2023.0060 |
| SSID | ssj0029071 |
| Score | 2.3621085 |
| Snippet | ABSTRACT Purpose: To validate the Barcelona magnetic resonance imaging predictive model (BCN-MRI PM) in men with pre-biopsy multiparametric MRI (mpMRI)... |
| SourceID | doaj pubmedcentral crossref |
| SourceType | Open Website Open Access Repository Enrichment Source Index Database |
| StartPage | 595 |
| SubjectTerms | Diagnosis Magnetic Resonance Imaging Original Prostatic Neoplasms |
| SummonAdditionalLinks | – databaseName: Scholars Portal Journals: Open Access dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fb9MwELbGkKq9oPFLjA1kJF5T3MR2kgeEVmBaJxWhjaK9WTnHZkVV0jUtbP89d05arQgJxKuTcxKfL_4-n--Osde4QqkydbT1lvuIHGdR5gtAwxNQ2hIRsqBo5PEnfTqRZ5fqcoetY0-6AWz-SO2ontRkMevfXN--Q4N_G6r35OLNxUCnaaTQdPuj4dkESV8s-xT0eY_dD24jOtEnN86FGPlg4GFrqR579deu9lgvyYk-Uf3cOytYSPT_-4HKOyvUyT570EFLftzOhYdsx1WPWG_cOc8fs_orYu62hBKvPUfkx4cU6ThDMB6Nz0d8vqB76f_HQ4Ec_vPKVfzzKDo__nDBf8T9AZ82fNW4ktP2LV-GxOghfhCfO6f4EUSuHKb1vEEC_oRNTj5-eX8adfUWIivTZBkVDtKsAKFiFyvvAKkG4hefilIKmepSeKUT663PtBdK-FiC00hxKR9NksU2ecp2q7pyzxhH2OcBilSCz5GC5aC003hfoewA27MDlq3H0NguGTnVxJgZIiWoCdOQJgxpwkzh-8qQJgxp4oDFG9F5m5HjX4SGpKiNACXVDg314pvpbNTY3OWWAIuziQStAVyiIJdZogtbasCX3lLzVm_bV6rpVUjVPWgT1Knn_y96yPboM9pzbUdsd7lYuRcIhJbwMkzrX28FAyE priority: 102 providerName: Scholars Portal |
| Title | Validation of the Barcelona-MRI predictive model when PI-RADS v2.1 is used with transperineal prostate biopsies |
| URI | https://pubmed.ncbi.nlm.nih.gov/PMC11446555 https://doaj.org/article/c9e9c2661ec34b66bbe35b94836acd6b |
| Volume | 50 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LT8QgECbGg_FiNGp8BxOvXdkWKD36jI-s8R1vpEMhrtl0N-6u_n1n6GpcL3rwwoGWQocBvgHmG8b2cIVSVe5p660ICR2cJSaUgANPQOUqRMiCvJE7V_rsQV48qadvob7oTlhDD9wIbt8VvnC0iniXSdAawGcKCmkyXbpKA82-ohCNMTXHdmNIn0LsD9s6zxOF47nVhZcxWoKpbJEn6NQCFHn6f96H_LbAnC6yhQky5AdNi5bYjK-XWf8RcXIT9oj3A0e0xg_JO7GHADrp3J7zwSudtNCcxWNQG_7-7Gt-fZ7cHhzf8be01ebdIR8PfcVpy5WPIpl59PnDygbk84Fok0O3Pxii0bzCHk5P7o_OkkmMhMTJPBslpYfclCBU6lMVPKB5gJgj5KKSQua6EkHpzAUXjA5CiZBK8BrNUuKQyUzqslU2W_drv8Y4QrUAUOYSQoFmUwFKe43vlcq1Md-sM_MpOOsmBOIUx6JnyZBAmdsoc0sytyRzSzK3JPN1ln4VHTQsGn8pdEi981WAiLBjBqqHnaiH_U09sNFTfTv1tekndfc50mu3G1I5tfEf9W-yefqh5lbaFpsdvY79NsKYEexEjcX08sZg2pHmA00Z9Ls |
| linkProvider | Directory of Open Access Journals |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Validation+of+the+Barcelona-MRI+predictive+model+when+PI-RADS+v2.1+is+used+with+transperineal+prostate+biopsies&rft.jtitle=International+Brazilian+Journal+of+Urology&rft.au=Juan+Morote&rft.au=Nahuel+Paesano&rft.au=Nat%C3%A0lia+Picola&rft.au=Jes%C3%BAs+Mu%C3%B1oz-Rodriguez&rft.date=2024-09-01&rft.pub=Sociedade+Brasileira+de+Urologia&rft.eissn=1677-6119&rft.volume=50&rft.issue=5&rft.spage=595&rft.epage=604&rft_id=info:doi/10.1590%2Fs1677-5538.ibju.2024.0204&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_c9e9c2661ec34b66bbe35b94836acd6b |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1677-5538&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1677-5538&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1677-5538&client=summon |